Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew Godkin

Showing results (51-60 of 69) with videos related to

Pageof 7
Sort By:
Frontiers in Immunology|April 27, 2018
<i>In Silico</i> and Structural Analyses Demonstrate That Intrinsic Protein Motions Guide T Cell Receptor Complementarity Determining Region Loop FlexibilityChristopher J Holland, Bruce J MacLachlan, Valentina Bianchi, et al.
JAMA Oncology|September 8, 2017
Effect of Modified Vaccinia Ankara-5T4 and Low-Dose Cyclophosphamide on Antitumor Immunity in Metastatic Colorectal Cancer: A Randomized Clinical TrialMartin Scurr, Tom Pembroke, Anja Bloom, et al.
Cancer Immunology Research|October 7, 2020
Immune Remodeling of the Extracellular Matrix Drives Loss of Cancer Stem Cells and Tumor RejectionAna Pires, Alexander Greenshields-Watson, Emma Jones, et al.
Nature Communications|February 9, 2012
Modification of the carboxy-terminal flanking region of a universal influenza epitope alters CD4⁺ T-cell repertoire selectionDavid K Cole, Kathleen Gallagher, Brigitte Lemercier, et al.
Molecular Therapy Oncolytics|September 11, 2020
Molecular Rules Underpinning Enhanced Affinity Binding of Human T Cell Receptors Engineered for ImmunotherapyRory M Crean, Bruce J MacLachlan, Florian Madura, et al.
European Journal of Immunology|September 12, 2012
Avidity of influenza-specific memory CD8+ T-cell populations decays over time compromising antiviral immunityIan R Humphreys, Mathew Clement, Morgan Marsden, et al.
Plos Pathogens|December 8, 2016
Cytomegalovirus-Specific IL-10-Producing CD4+ T Cells Are Governed by Type-I IFN-Induced IL-27 and Promote Virus PersistenceMathew Clement, Morgan Marsden, Maria A Stacey, et al.
Journal for Immunotherapy of Cancer|October 23, 2020
Enhanced antitumor immunity through sequential targeting of PI3Kδ and LAG3Sarah Nicol Lauder, Kathryn Smart, Veerle Kersemans, et al.
Immunology|November 14, 2021
Whole blood-based measurement of SARS-CoV-2-specific T cells reveals asymptomatic infection and vaccine immunogenicity in healthy subjects and patients with solid-organ cancersMartin J Scurr, Wioleta M Zelek, George Lippiatt, et al.
European Journal of Immunology|May 16, 2019
TCR-induced alteration of primary MHC peptide anchor residueFlorian Madura, Pierre J Rizkallah, Mateusz Legut, et al.
Pageof 7

Showing results (51-60 of 69) with videos related to

Sort By:
Pageof 7
Frontiers in Immunology|April 27, 2018
<i>In Silico</i> and Structural Analyses Demonstrate That Intrinsic Protein Motions Guide T Cell Receptor Complementarity Determining Region Loop FlexibilityChristopher J Holland, Bruce J MacLachlan, Valentina Bianchi, et al.
JAMA Oncology|September 8, 2017
Effect of Modified Vaccinia Ankara-5T4 and Low-Dose Cyclophosphamide on Antitumor Immunity in Metastatic Colorectal Cancer: A Randomized Clinical TrialMartin Scurr, Tom Pembroke, Anja Bloom, et al.
Cancer Immunology Research|October 7, 2020
Immune Remodeling of the Extracellular Matrix Drives Loss of Cancer Stem Cells and Tumor RejectionAna Pires, Alexander Greenshields-Watson, Emma Jones, et al.
Nature Communications|February 9, 2012
Modification of the carboxy-terminal flanking region of a universal influenza epitope alters CD4⁺ T-cell repertoire selectionDavid K Cole, Kathleen Gallagher, Brigitte Lemercier, et al.
Molecular Therapy Oncolytics|September 11, 2020
Molecular Rules Underpinning Enhanced Affinity Binding of Human T Cell Receptors Engineered for ImmunotherapyRory M Crean, Bruce J MacLachlan, Florian Madura, et al.
European Journal of Immunology|September 12, 2012
Avidity of influenza-specific memory CD8+ T-cell populations decays over time compromising antiviral immunityIan R Humphreys, Mathew Clement, Morgan Marsden, et al.
Plos Pathogens|December 8, 2016
Cytomegalovirus-Specific IL-10-Producing CD4+ T Cells Are Governed by Type-I IFN-Induced IL-27 and Promote Virus PersistenceMathew Clement, Morgan Marsden, Maria A Stacey, et al.
Journal for Immunotherapy of Cancer|October 23, 2020
Enhanced antitumor immunity through sequential targeting of PI3Kδ and LAG3Sarah Nicol Lauder, Kathryn Smart, Veerle Kersemans, et al.
Immunology|November 14, 2021
Whole blood-based measurement of SARS-CoV-2-specific T cells reveals asymptomatic infection and vaccine immunogenicity in healthy subjects and patients with solid-organ cancersMartin J Scurr, Wioleta M Zelek, George Lippiatt, et al.
European Journal of Immunology|May 16, 2019
TCR-induced alteration of primary MHC peptide anchor residueFlorian Madura, Pierre J Rizkallah, Mateusz Legut, et al.
Pageof 7